The efficacy and safety of escitalopram augmentation of risperidone and olanzapine in treatment resistant schizophrenia: a double blind placebo controlled pilot study
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Escitalopram; Olanzapine; Risperidone
- Indications Schizophrenia
- Focus Therapeutic Use
- 07 Dec 2010 Biomarkers information updated
- 06 Dec 2010 Actual end date (Jul 2007) added as reported by ClinicalTrials.gov.
- 06 Dec 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.